GlassScriptPhysician profile
Jamie Huppmann
NPI 1205477734
$1,843.08
in general payments reported to CMS, 2019-2025
20 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $244 · 2022: $586 · 2023: $561 · 2024: $348 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.28 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $575.02 | 2021-2024 | |
| Astellas Pharma US INC | $430.02 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $104.95 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.99 | 2022-2024 | |
| Therapeuticsmd, INC. | $78.72 | 2021-2022 | |
| Shield Therapeutics INC | $69.94 | 2024 | |
| Organon LLC | $68.59 | 2022-2023 | Nexplanon |
| Mycovia Pharmaceuticals, INC. | $56.37 | 2022-2023 | Vivjoa |
| Merck Sharp & Dohme LLC | $53.39 | 2023-2024 | Gardasil 9, Gardasil |
| Aspira Women'S Health INC | $49.92 | 2022-2023 | Ova1 |
| Pfizer INC. | $47.73 | 2021-2024 | |
| Scynexis, INC. | $31.45 | 2022 | |
| Hologic Sales and Service, LLC | $30.39 | 2022 | |
| Mylan Pharmaceuticals INC. | $29.81 | 2022 | |
| Exeltis, USA INC. | $27.52 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $20.35 | 2021 | |
| Coopersurgical, INC. | $19.77 | 2023 | Paragard T 380a |
| Avion Pharmaceuticals | $16.01 | 2023 | Balcoltra |
| Evofem Biosciences, INC. | $15.98 | 2022 | |
| Millicent US INC | $14.16 | 2024 | Intrarosa, Femring |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Huppmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.